Skip to main content

Heart Transplant clinical trials at UC Health

5 in progress, 4 open to eligible people

Showing trials for
  • Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation

    open to eligible people ages 18 years and up

    Demonstrate the impact of the Molecular Microscope Diagnostic System as the standard of care for heart transplant patients.

    at UCLA

  • Stress Cardiac MRI in Heart Transplant

    open to eligible people ages 18 years and up

    The investigators will use cardiac MRI to measure the myocardial perfusion reserve and amount of myocardial edema and fibrosis in heart-transplant patients with nonspecific allograft dysfunction in contrast to those with normal graft function. The investigators hypothesize that patients with nonspecific allograft dysfunction will demonstrate decreased myocardial perfusion reserve, related to microvascular allograft vasculopathy, compared to those with normal graft function.

    at UCSD

  • Surveillance HeartCare® Outcomes Registry

    open to eligible people ages 15 years and up

    This is an observational registry to assess the clinical utility of surveillance using HeartCare testing services, in association with clinical care of heart transplant recipients.

    at UCSD

  • Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score

    open to eligible people ages up to 21 years

    The TEAMMATE Trial will enroll 210 pediatric heart transplant patients from 25 centers at 6 months post-transplant and follow each patient for 2.5 years. Half of the participants will receive everolimus and low-dose tacrolimus and the other half will receive tacrolimus and mycophenolate mofetil. The trial will determine which treatment is better at reducing the cumulative risk of coronary artery vasculopathy, chronic kidney disease and biopsy proven-acute cellular rejection without an increase in graft loss due to all causes (e.g. infection, PTLD, antibody mediated rejection).

    at UCLA

  • Outcomes AlloMap Registry: the Long-term Management and Outcomes of Heart Transplant Recipients With AlloMap Testing

    Sorry, in progress, not accepting new patients

    The objective of this registry is to observe short and long term clinical outcomes in heart transplant recipients who receive regular AlloMap testing as part of allograft rejection surveillance.

    at UCLA

Last updated: